Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
To observe the PFS of yttrium \[90Y\] microsphere injection combined with FOLFIRI and bevacizumab in second-line treatment of CRLM.
Epistemonikos ID: 1cd74aca3b39f017e73b3ac4dc762fa27e892d90
First added on: Jul 01, 2024